hyper polypharmacy
1 article · search the full text for this term
-
Polypharmacy and the need of deprescribing in Geriatric Chronic Kidney Disease patients
Abstract: Polypharmacy and Hyper polypharmacy pose risk for geriatric population by increasing drug interactions and side effects. This calls for deprescription to remove potentially inappropriate medications (PIM) from their prescription. BEERs criteria (BC) was used to classify medications for PIM. It also includes addition of a new drug, dose reduction and replacement with a newer drug. This study was conducted to find out the need of deprescription in geriatric population suffering …
Published in Research & Reviews: A Journal of Pharmacognosy · Vol. 9, Issue 1, 2022 · pp. 1–4 Read article